KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - AccuredReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - AccuredReceivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Twist Bioscience (TWST) Receivables - Accured (2023 - 2026)

Twist Bioscience has reported Receivables - Accured over the past 4 years, most recently at $900000.0 for Q1 2026.

  • Quarterly Receivables - Accured fell 25.0% to $900000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $900000.0 through Mar 2026, down 25.0% year-over-year, with the annual reading at $1.2 million for FY2025, 20.0% up from the prior year.
  • Receivables - Accured was $900000.0 for Q1 2026 at Twist Bioscience, up from $800000.0 in the prior quarter.
  • Over five years, Receivables - Accured peaked at $1.4 million in Q4 2024 and troughed at $800000.0 in Q4 2025.
  • The 4-year median for Receivables - Accured is $1.2 million (2023), against an average of $1.1 million.
  • The largest YoY upside for Receivables - Accured was 20.0% in 2025 against a maximum downside of 42.86% in 2025.
  • A 4-year view of Receivables - Accured shows it stood at $1.2 million in 2023, then increased by 16.67% to $1.4 million in 2024, then crashed by 42.86% to $800000.0 in 2025, then grew by 12.5% to $900000.0 in 2026.
  • Per Business Quant, the three most recent readings for TWST's Receivables - Accured are $900000.0 (Q1 2026), $800000.0 (Q4 2025), and $1.2 million (Q3 2025).